The regional distribution of N1'-([C-11]methyl)naltrindole ([C-11]MeNTI) in vivo in mouse brain correlates with established delta-opioid receptor densities in vitro. [C-11]MeNTI binding is blocked by naltrindole, a delta-antagonist, but not by cyprodime, a mu-antagonist, of by (+/-)-U50,488, a kappa-agonist. Thus, [C-11]MeNTI selectively labels central delta-opioid receptors in vivo in mouse, and shows promise for positron emission tomography studies of delta sites in human brain.